Free

AUS Delegation to the Advanced Therapies & Regenerative Medicine Congress

Event Information

Share this event

Date and Time

Location

Location

Business Design Centre

London

N1 0HZ

United Kingdom

View Map

Event description

Description

MTPConnect is a Supporting Partner at the Advanced Therapies & Regenerative Medicine Congress the world's premier congress on regenerative medicine. Our CEO, Dr Dan Grant, is speaking on Australian regenerative medicine opportunities.

If you are interested in participating in our Australian delegation, MTPConnect has discounted packages for a 2x1 booth in the Innovation Zone. Please get in touch to discuss your interest, by emailing events@mtpconnect.org.au.

Deadline to register with us is March 15.

Why this congress is a must attend:

STRONG AGENDA

Governed by a Scientific Advisory Board made up of 26 leading pioneers of the advanced therapies industry, the agenda, topics and speakers are relevant and cutting edge.

MORE CEOs, CSOs AND DECISON MAKERS

Hear from over 250 senior speakers including Nobel prize-winner Shinya Yamanaka, Kathy High (Spark Therapeutics), Pascal Touchon (Novartis), Bob Smith (Pfizer), Andrew Obenshain (bluebird bio) and Roy Baynes (Merck).

EIGHT TRACKS AND NEW PRE-CONFERENCE DAY

Attend focused sessions across multiple tracks AND a new pre-conference day packed with workshops and summits. Take this unique opportunity to gain not only the sessions focused on specific therapy areas (gene therapy, CAR-T, immunotherapy, cell therapy, regenerative medicine, cord blood) but also on the manufacture, regulation, reimbursement, market access and delivery of new therapeutics to patients.

KEYNOTE PLENARY SESSIONS

  • Nobel Prize-winner: Shinya Yamanaka gives a keynote address about the recent progress in iPS cell research and application

  • Kathy High from Spark Therapeutics will be giving a fireside chat with Vivienne Parry OBE about the future of gene therapy.

  • Join bluebird bio, Novartis, Pfizer, Cellectis, Spark Therapeutics & Oxford Biomedica who will speak about how gene therapy can be used now and, in the future, to treat and cure diseases in the clinic.

  • The future state of regulatory and compliance for cold chain distribution of regenerative therapies by Mark Sawicki, CCO, Cryoport.

  • Roy Baynes from Merck and Frederic Triebel from Immutep will discuss innovations in cellular and combination immunotherapy.

  • Derek Jantz (Precision Biosciences) and Fred Chereau (LogicBio Therapeutics) will be discussing gene editing in technology and how we can overcome challenges such as off target effects.

Share with friends

Date and Time

Location

Business Design Centre

London

N1 0HZ

United Kingdom

View Map

Save This Event

Event Saved